Salt intake and reductions in arterial pressure and proteinuria: Is there a direct link?

American Journal of Hypertension

Volumn 9, Issue 12 SUPPL. 1, 1996, Pages S200-S206

  Bakris, George L ^a,c   Weir, Matthew R ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c RUSH UNIVERSITY   (United States)

Author keywords

Antihypertensive therapy; Diet; Drugs; Salt; Salt sensitivity

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE;

ARTERIAL PRESSURE; DIET; HUMAN; HYPERTENSION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SALT INTAKE; SODIUM RESTRICTION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; PROTEINURIA; SODIUM CHLORIDE;

EID: 0030472083     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00392-5     Document Type: Article

References (75)

1. Stamler J: Dietary salt and blood pressure, in Lee KT, Oike Y, Kanazawa T (eds): The Third International Conference on Nutrition in Cardiovascular Diseases. Ann NY Acad Sci 1993;676:122-156.
2. Dyer AR, Stamler R, Elliott P, Stamler J: Dietary salt and blood pressure. Nature Med 1995;1:994-996.
3. Muntzel M, Drueke T: A comprehensive review of the salt and blood pressure relationship. 1992;5:1S-42S.
4. Intersalt Cooperative Research Group: Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24-hour urinary sodium and potassium excretion. Br Med J 1988;297:319-328.
5. de Wardener HE, MacGregor GA: The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension. Medicine (Baltimore) 1983;62:310-326.
6. Guyton AC, Langston JB. Navar G: Theory for renal autoregulation by feedback at the juxtaglomerular apparatus. Circ Res 1964;14/15(suppl I):1187-1197.
7. Luft FC, Rankin LI, Bloch R, et al: Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation 1979;60:697-706.
8. Folkow B, Ely DL: Cardiovascular and sympathetic effects of 240-fold salt intake variations - studies in rats with complications to man. Acta Physiol Scand 1989; 136:89-96.
9. Volpe M, Lembo G, Morganti A, et al: Contribution of the renin-angiotensin system and of the sympathetic nervous system to blood pressure homeostasis during chronic restriction of sodium intake. 1988;1:353-358.
10. Campese VM, Parise M, Karubian F, Bigazzi R: Abnormal renai hemodynamics in black salt sensitive patients with hypertension. Hypertension 1991;13:805-821.
11. Bank N, Lahorra MA, Aynedjian HS, Wilkes BM: Sodium restriction corrects hyperfiltration of diabetes. Am J Physiol 1988;254:F668-F676.
12. Bigazzi R, Bianchi S, Baldan D, et al: Micro-albuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 1994;23:195-199.
13. Weir MR, Dengel DR, Behrens MT, Coldberg AP: Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension 1995; 25:1339-1344.
14. Campese VM: Salt-sensitivity in hypertension. Hypertension 1992;19:403-418.
15. Epstein M, Sowers JR: Diabetes mellitus and hypertension. Hypertension 1992;19:403-418.
16. Bakris GL: Microalbuminuria: prognostic implications. Curr Opin Nephrol Hypertens 1996;5:219-223.
17. Mogensen CE, Schmitz A, Damsgaard EM: Microalbuminuria: a predictor of proteinuria and early mortality in NIDDM. Diab Nutr Metab 1990;3(suppl 1):77-86
18. Abbott KC, Sanders LR, Bakris GL: Microalbuminuria in non-insulin-dependent diabetes mellitus: Implications for renal survival. Arch Intern Med 1994;154:146-153.
19. Heeg JE, de Jong IE, van der Hem GK, de Zeeuw D: Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989;36:272-280.
20. Bakris GL, Smith AC: Effects of sodium intake on albunin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists. Ann Int Med 1996;125:201-204.
21. Maki DD, Ma JZ, Louis TA, Kasiske BL: Effects of antihypertensive agents on the kidney. Arch Intern Med 1995;155:1073-1082
22. Bakris GL, Williams B: ACE inhibitors and calcium antagonists alone or combined: is there a difference on progression of diabetic renal disease? J Hypertens 1995; 13(suppl 2):S95-S101
23. Freis ED, Wanko A, Wilson IM, Parrish AE: Treatment of essential hypertension with chlorothiazide (diuril). JAMA 1958;166:137-145.
24. Fallis N, Ford RV: Electrolyte excretion and hypotensive response. JAMA 1961;176:581-584.
25. Ram CVS, Garrett BN, Kaplan NM: Moderate sodium restriction and various diuretics in the treatment of hypertension. Arch Intern Med 1981;141:1015-1019.
26. Parijs J, Joossens JV, Van der Linder L, et al: Moderate sodium restriction and diuretics in the treatment of hypertension. Am Heart J 1973;85:22-34.
27. Erwteman TM, Nagelkerke N, Lusen J, et al: β-Blockade, diuretics, and salt restriction for the management of mild hypertension: a randomized double blind trial. Br Med J 1984;289:406-409.
28. Kimura G, Deyunchi F, Kojima S, et al: Antihypertensive drugs and sodium restriction. 1988;1:372-379.
29. MacGregor GA, Markandu ND, Singer DRJ, et al: Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. Br Med J 1987;294:531-534.
30. Langford HG, Blaufox MD, Oberman A, et al: Dietary therapy slows the return of hypertension after stopping prolonged medication. JAMA 1985;253:657-664.
31. Van Brummelen P, Schalekamp M, de Graeff J: Influence of sodium intake on hydrochlorothiazide-induced changes in blood pressure, serum electrolytes. Acta Med Scand 1978;204:151-157.
32. Bing RF, Thurston H, Sivales JD: Salt intake and diuretic treatment of hypertension. Lancet 1979;ii:121-123.
33. Weir MR, Saunders E: Racial similarity in response to the angiotensin converting enzyme inhibitor trandolapril. Ethnicity Dis 1996;7:184.
34. MacGregor GA, Cappuccio FP, Markandu ND: Sodium intake, high blood pressure, and calcium channel blockers. Am J Med 1987;82(suppl 3B):16-22.
35. MacGregor GA, Markandur ND, Smith ST, et al: Angiotensin converting enzyme inhibition reveals an important role for the renin system in the control of normal and high blood pressure in man. Clin Exp Hypertens 1983;5:1367-1380.
36. Weir MR, Saunders E: Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. Hypertension 1995; 26:124-130.
37. Oshima T, Matsuura H, Matsumoto K, Kido K: Role of cellular calcium in salt sensitivity of patients with essential hypertension. Hypertension 1988;11:703-707.
38. Nicholson JF, Resnick LM, Laragh JH: The impact of dietary sodium intake on the hypertensive response of verapamil in essential hypertension. J Clin Hypertens 1986;3:143S-147S.
39. Morgan T, Anderson A, Wilson D, et al: Paradoxical effect of sodium restriction on blood pressure in people on slow-channel calcium drugs. Lancet 1986 793.
40. MacGregor CA, Markandu ND, Singer DRJ, et al: Paradoxical effect of sodium restriction on blood pressure in people on slow-channel calcium drugs. Lancet 1986 793.
41. Weir MR, Hall PS, Behrens MT: Greater antihypertensive response to the calcium antagonist isradapine in salt-sensitive versus salt-resistant hypertensives (abst). J Am Soc Nephrol 1994;7:8.
42. Flack JM, Grimm RH, Jr., Yunis C, et al for the TOHMS Research Group: Ethnic blood pressure response patterns in the Treatment of Mild Hypertension TOHMS) Study. Arch Intern Med (in press).
43. Neaton JD, Grimm RH, Jr., Prineas RJ, et al for the Treatment of Mild Hypertension Study Research Group: Treatment of Mild Hypertension Study. Final results. JAMA 1993;270:713-724.
44. Lutt FC, Grim CE, Higgins JT, Weinberger MH: Differences in response to sodium administration in normotensive white and black subjects. J Lab Clin Med 1977; 90:555-562.
45. Grim CE, Lutt FC, Miller JZ: Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis 1980;33:87-94.
46. Beard TC, Cooke HM, Gray WR, Barge R: Randomized controlled trial of a no-added-sodium diet for mild hypertension. Lancet 1982;ii:455-458.
47. Weinberger MH, Cohen SJ, Miller JZ, et al: Dietary sodium restriction as adjunctive treatment of hypertension. JAMA 1988;6:2561-2565.
48. Stamler R, Stamler J, Grimm R, et al: Nutritional therapy for high blood pressure: final report of a four-year randomized controlled trial: the Hypertension Control Program. JAMA 1987;257:1484-1491.
49. Law MR, Frost CD, Wald NJ: By how much does dietary salt reduction lower blood pressure? I. Analysis of observational data among populations. Br Med J 1991;302:311-315.
50. Gillum RF, Princas RJ, Jeffery RW: Nonpharmacologic therapy of hypertension: the independent effects of weight reduction and sodium restriction in overweight borderline hypertensive patients. Am Heart J 1983; 105:128-133.
51. Levey AS, Madaio MP, Perrone RO: Laboratory assessment of renal disease: clearance urinalysis and renal biopsy, in Brenner B (ed): The Kidney. WB Saunders, Philadelphia, 1991, pp 940-941.
52. Brenner BM, Hostetter TH, Humes HD: Molecular basis of proteinuria of glomerular origin. N Engl J Med 1978;298:826-832.
53. Rennke HG, Olson JL, Venkatachalam MA: Glomerular filtration of macromolecules: normal mechanisms and the pathogenesis of proteinuria. Contrib Nephrol 1981; 24:30-42.
54. Kannel WB, Stampfer MJ, Castelli WP, Verter J: The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984;108:1347-1352.
55. Samuelson O, Wilhelmsen L, Elmfeldt O, et al: Predictors of cardiovascular morbidity in treated hypertension results from the primary preventive trial in Goteborg Sweden. J Hypertens 1984;3:167-176.
56. Bulpitt CJ, Beevers DG, Butler A, et al: The survival of treated hypertensive patients and their causes of death: report from the DHSS Hypertensive Care Computing Project (DHCCP). J Hypertens 1986;4:93-99.
57. Mogensen CE: Microalbuminuria predicts clinical: proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1986;310:356-360.
58. Karlberg B: Calcium antagonists in essential hypertension: effect on renal hemodynamics and microalbuminuria. J Intern Med 1992;231:247-252.
59. Bianchi S, Bigazzi R, Baldari G, Campese VM: Microabluminuria in patients with essential hypertension: effect of several antihypertensive drugs. Am J Med 1992;93:525-528.
60. Bakris GL, Stein JH: Diabetic nephropathy. Disease-a-Month 1993,39:573-611.
61. Hemmelder MH, de Zeeuw D, Buler H, de Jong PE: Hydrochlorothiazide potentiates the antiproteinuric efficacy of ACE inhibition comparable to dietary salt restriction (abst). J Am Soc Nephrol 1995;6:420.
62. Weir MR: Differing effects of antihypertensive agents on urinary albumin excretion. Am J Nephrol (in press).
63. Bakris GL Barnhill BW, Sadler R: Treatment of arterial hypertension in diabetic man: importance of therapeutic selection. Kidney Int 1992;41:898-906.
64. Slataper S, Vicknair N, Sadler R, Bakris GI: Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 1993;118:129-138.
65. Bakris G: Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 1990;112:707-708.
66. Weidmann P, Schneider M, Bohlen L: Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis. Nephrol Dial Trans 1995;10(suppl 9):39-45.
67. Bakris GI., Smith AC: Effects of two different calcium antagonists on glomerular permeability and proteinuria: A two year randomized prospective study. J Am Soc Nephrol (in press).
68. Demarie BK, Bakris GL: Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 1990;113:987-988.
69. Hartmann A, Lund K, Hagel L, et al: Contrasting short term effects of nifedipine on glomerular and tubular functions in glomerulonephritic patients. J Am Soc Nephrol 1994;5:1385-1390.
70. Barba G, Cippuccio FP, Russo L, et al: Renal function and blood pressure response to dietary salt restriction in normotensive men. Hypertension 1996;27:1160-1164
71. Dworkin LD, Benstein JA, Toibert E, Feiner HD: Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease. J Am Soc Nephrol 1996;7:437-442.
72. Grey A, Braatvedt G, Holdaway I: Moderate dietary salt restriction does not alter insulin resistance or serum lipids in normal men. 1996;9:317-322.
73. National High Blood Pressure Education Program Working Group on Hypertension and Renal Disease: 1995 Update of the working group reports on chronic renal failure and renovascular hypertension. Arch Intern Med 1996;156:1938-1946.
74. Peterson JC, Adler S, Burkart JM, et al: Blood pressure control, proteinuria and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann intern Med 1995;123:754-762.
75. Modification of Dietary Protein and Renal Disease Group: Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the modification of die in renal disease study. J Am Soc Nephrol 1996;7:556-566.